Isavuconazole-induced Acute Liver Failure in a Pediatric Patient With Invasive Aspergillosis
Isavuconazole is a new azole approved for adults with invasive aspergillosis and mucormycosis, with a favorable hepatic tolerability reported in Phase III trials. Here, we report on a case of drug-induced liver failure related to isavuconazole in a pediatric patient treated for invasive aspergillosis after bone marrow transplant.
Source: The Pediatric Infectious Disease Journal - Category: Infectious Diseases Tags: Antimicrobial Reports Source Type: research
More News: Aspergillosis | Bone Marrow Transplant | Infectious Diseases | Liver | Liver Transplant | Pediatrics | Transplant Surgery | Transplants | Urology & Nephrology